<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03115983</url>
  </required_header>
  <id_info>
    <org_study_id>LSS17001</org_study_id>
    <nct_id>NCT03115983</nct_id>
  </id_info>
  <brief_title>LimiFlex Clinical Trial for the Treatment of Degenerative Spondylolisthesis With Spinal Stenosis</brief_title>
  <official_title>A Concurrently Controlled Study of the LimiFlex™ Paraspinous Tension Band in the Treatment of Lumbar Degenerative Spondylolisthesis With Spinal Stenosis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Empirical Spine, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Morley Research Consortium</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Biomedical Statistical Consulting</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Medical Metrics Diagnostics, Inc</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Empirical Spine, Inc.</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_unapproved_device>Yes</is_unapproved_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The LimiFlex™ Clinical Trial is a prospective, concurrently controlled, multi-center study to&#xD;
      evaluate the safety and effectiveness of decompression and stabilization with the Empirical&#xD;
      Spine LimiFlex™ Paraspinous Tension Band compared to decompression and transforaminal lumbar&#xD;
      interbody fusion (TLIF) with concomitant posterolateral fusion (PLF) for the treatment of&#xD;
      lumbar degenerative spondylolisthesis (Grade I per Meyerding classification) with spinal&#xD;
      stenosis. Clinical trial sites will enroll solely LimiFlex subjects or solely TLIF/PLF&#xD;
      subjects.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The LimiFlex™ Paraspinous Tension Band is a new stabilization option for patients being&#xD;
      treated with surgical decompression for degenerative spondylolisthesis. The LimiFlex does not&#xD;
      require pedicle screws to anchor to the spine; instead, two dynamic rods are attached to&#xD;
      pedicle-sparing straps which encircle adjacent spinous processes.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">July 17, 2017</start_date>
  <completion_date type="Anticipated">July 2025</completion_date>
  <primary_completion_date type="Anticipated">July 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>This is a multi-center, prospective, concurrently controlled, non-blinded study. Balance between groups will be achieved through sub classification using propensity scores. Prospective patient sample supplemented with retrospective and/or historical control subjects.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Composite Clinical Success</measure>
    <time_frame>24 Months</time_frame>
    <description>Individual success for patients in the investigational LimiFlex or control fusion arm is assessed with Composite Clinical Success (CCS) criteria. To be considered a success, a subject must demonstrate all of the following:&#xD;
15 point improvement in Oswestry Disability Index (100 point scale)&#xD;
Absence of a new or worsening, persistent neurological deficit&#xD;
Absence of additional surgical intervention&#xD;
Absence of device integrity failures</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Oswestry Disability Index (ODI)</measure>
    <time_frame>Both groups: 6 wks, 3 mo, 6 mo, 12 mo, 24 mo, 36 mo, 48 mo, 60 mo</time_frame>
    <description>Oswestry Disability Index (ODI)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Neurological Status</measure>
    <time_frame>Both groups: 6 wks, 3 mo, 6 mo, 12 mo, 24 mo, 36 mo, 48 mo, 60 mo</time_frame>
    <description>Neurological Status</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Additional surgical interventions</measure>
    <time_frame>Both groups: 6 wks, 3 mo, 6 mo, 12 mo, 24 mo, 36 mo, 48 mo, 60 mo</time_frame>
    <description>Additional surgical interventions</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Absence of device integrity failures defined as device breakage, device separation or disassembly, or device dislocation</measure>
    <time_frame>Both groups: 6 wks, 3 mo, 6 mo, 12 mo, 24 mo, 36 mo, 48 mo, 60 mo</time_frame>
    <description>Absence of device integrity failures defined as device breakage, device separation or disassembly, or device dislocation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Estimated blood loss</measure>
    <time_frame>Procedure</time_frame>
    <description>estimated blood loss and units of blood transfused</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Length of procedure</measure>
    <time_frame>Procedure</time_frame>
    <description>Length of procedure (skin to skin)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hospital stay</measure>
    <time_frame>Immediately upon discharge</time_frame>
    <description>Hospital stay</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Return to normal activities of daily living</measure>
    <time_frame>Both groups: 6 wks, 3 mo, 6 mo, 12 mo, 24 mo, 36 mo, 48 mo, 60 mo</time_frame>
    <description>Length of time for subject to return to his/her normal activities of daily living.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Work status</measure>
    <time_frame>Both groups: 6 wks, 3 mo, 6 mo, 12 mo, 24 mo, 36 mo, 48 mo, 60 mo</time_frame>
    <description>Work status and days to return to work (as appropriate)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain medication including narcotics usage</measure>
    <time_frame>Both groups: 6 wks, 3 mo, 6 mo, 12 mo, 24 mo, 36 mo, 48 mo, 60 mo</time_frame>
    <description>Medication use for pain, including narcotic, usage</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Visual analog scale (VAS) leg pain</measure>
    <time_frame>Both groups: 6 wks, 3 mo, 6 mo, 12 mo, 24 mo, 36 mo, 48 mo, 60 mo</time_frame>
    <description>Leg pain as measured on a Visual Analog Scale (VAS)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Visual analog scale (VAS) back pain</measure>
    <time_frame>Both groups: 6 wks, 3 mo, 6 mo, 12 mo, 24 mo, 36 mo, 48 mo, 60 mo</time_frame>
    <description>Back pain as measured on a Visual Analog Scale (VAS)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Zurich claudication questionnaire (ZCQ)</measure>
    <time_frame>Both groups: 6 wks, 3 mo, 6 mo, 12 mo, 24 mo, 36 mo, 48 mo, 60 mo</time_frame>
    <description>Zurich claudication questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>SF-12 Quality of Life survey</measure>
    <time_frame>Both groups: 6 wks, 3 mo, 6 mo, 12 mo, 24 mo, 36 mo, 48 mo, 60 mo</time_frame>
    <description>SF-12 Health Survey</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient satisfaction</measure>
    <time_frame>Both groups: 6 wks, 3 mo, 6 mo, 12 mo, 24 mo, 36 mo, 48 mo, 60 mo</time_frame>
    <description>Patient satisfaction questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Radiographic fusion status</measure>
    <time_frame>Both groups: 6 wks, 3 mo, 6 mo, 12 mo, 24 mo, 36 mo, 48 mo, 60 mo</time_frame>
    <description>Radiographic fusion status</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">315</enrollment>
  <condition>Degenerative Spondylolisthesis</condition>
  <condition>Lumbar Spinal Stenosis</condition>
  <arm_group>
    <arm_group_label>LimiFlex</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Posterior dynamic stabilization with the LimiFlex Paraspinous Tension Band</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Fusion</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Transforaminal lumbar interbody fusion with concomitant posterolateral fusion with pedicle screw instrumentation</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>LimiFlex</intervention_name>
    <description>LimiFlex implantation at a single level after surgical decompression.</description>
    <arm_group_label>LimiFlex</arm_group_label>
    <other_name>LimiFlex Paraspinous Tension Band</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Fusion Instrumentation</intervention_name>
    <description>Titanium alloy top-loading, polyaxial pedicle screws and cylindrical, titanium alloy rod instrumentation using autograft and/or allograft bone (i.e., cancellous and/or corticocancellous bone only), and/or a synthetic bone graft extender that is on-label for these indications (i.e., decorticated posterolateral gutter only). The TLIF requires a single PEEK or Titanium TLIF cage cleared by FDA for this indication filled with autograft and/or allograft bone (i.e., cancellous and/or corticocancellous bone only).</description>
    <arm_group_label>Fusion</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Decompression</intervention_name>
    <description>Surgical decompression at one or two contiguous levels for L1 to S1.</description>
    <arm_group_label>Fusion</arm_group_label>
    <arm_group_label>LimiFlex</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Fusion</intervention_name>
    <description>Transforaminal lumbar interbody fusion (TLIF) with concomitant posterolateral fusion (PLF) at a single level after surgical decompression.</description>
    <arm_group_label>Fusion</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria (patients must meet ALL of the following criteria to be eligible for&#xD;
        participation in the study):&#xD;
&#xD;
          1. Lumbar degenerative spondylolisthesis (Grade I per Meyerding classification), at one&#xD;
             level from L1 to S1, with radiographic confirmation using X-ray;&#xD;
&#xD;
             a. Grade I spondylolisthesis per Meyerding classification includes up to 25% anterior&#xD;
             translation of a vertebra relative to the superior endplate of the subjacent vertebra&#xD;
             at the index level. A patient is considered to have spondylolisthesis with a minimum&#xD;
             10% anterolisthesis at the affected level in a lateral x-ray image.&#xD;
&#xD;
          2. Lumbar spinal stenosis, at the level diagnosed with degenerative spondylolisthesis,&#xD;
             and confirmed radiographically using CT or MRI;&#xD;
&#xD;
             a. At the index level, lumbar spinal stenosis is at least moderate lumbar canal&#xD;
             stenosis, defined as more than 25% reduction of the cross-sectional area compared with&#xD;
             the next adjacent normal level, with nerve root crowding compared with the normal&#xD;
             level, as determined by the investigator on CT Scan or MRI.&#xD;
&#xD;
          3. Neurogenic claudication or radiculopathy symptoms including leg pain, muscle weakness,&#xD;
             and/or sensation abnormality, with or without back pain as evidenced by patient&#xD;
             history;&#xD;
&#xD;
          4. Persistent symptoms despite at least 6 months of conservative treatment that may&#xD;
             include but is not limited to physical therapy, medications, and/or epidural&#xD;
             injections;&#xD;
&#xD;
          5. A pre-operative Visual Analog Scale (VAS) leg pain score of ≥50 on a 100 mm scale;&#xD;
&#xD;
          6. A pre-operative Oswestry Disability Index (ODI) score ≥35 points on a 100-point scale;&#xD;
&#xD;
          7. Candidate for surgical decompression and stabilization at only one level between&#xD;
             L1-S1;&#xD;
&#xD;
          8. Posterior element anatomy is appropriate for interspinous fixation including&#xD;
             prediction of presence of spinous processes of segment to be instrumented following&#xD;
             decompression (investigational AND control groups) and a prediction of &gt;50% of facet&#xD;
             joints present following decompression (investigational group only);&#xD;
&#xD;
          9. ≥25-80 years of age and skeletally mature;&#xD;
&#xD;
         10. Patient has the necessary mental capacity to participate and is willing and able to&#xD;
             participate in the study for the duration of the study follow-up and is able to comply&#xD;
             with study requirements; and&#xD;
&#xD;
         11. Patient is willing to provide Informed Consent for study participation.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. A primary and predominate diagnosis of discogenic back pain;&#xD;
&#xD;
          2. A primary and predominate diagnosis of facet-mediated back pain;&#xD;
&#xD;
          3. Back or non-radicular leg pain of unknown etiology;&#xD;
&#xD;
          4. Significant peripheral vascular disease causing vascular claudication;&#xD;
&#xD;
          5. Significant peripheral neuropathy caused by conditions other than spinal stenosis;&#xD;
&#xD;
          6. History of fixed or permanent neurological deficit related to spinal cord injury;&#xD;
&#xD;
          7. History of any previous surgery* at any level in the lumbosacral spine except for a&#xD;
             discectomy or decompression;&#xD;
&#xD;
          8. History of any previous surgery* at the level planned for treatment;&#xD;
&#xD;
               -  previous surgery includes spinal stimulator placement but does NOT include&#xD;
                  epidural injections&#xD;
&#xD;
          9. Isthmic spondylolisthesis or spondylolysis (pars fracture) at any level in the lumbar&#xD;
             spine;&#xD;
&#xD;
         10. Clinically significant compromise of vertebrae at L1 to S1 levels due to osteoporotic&#xD;
             vertebral compression fracture or any traumatic, neoplastic, metabolic or infectious&#xD;
             pathology or congenital abnormality;&#xD;
&#xD;
         11. Spinous process fracture(s) or other posterior element fracture(s) of the segment to&#xD;
             be instrumented that would preclude secure fixation of the LimiFlex Device to the&#xD;
             spinous process;&#xD;
&#xD;
         12. Spinous process insufficiency or deformity that would preclude secure fixation of the&#xD;
             LimiFlex Device to the spinous process including spinous process length &lt;10 mm from&#xD;
             lamina to dorsal tip or other significant deformity due to trauma, or congenital&#xD;
             abnormality such as spina bifida occulta at the planned instrumented level that would&#xD;
             preclude secure fixation of the LimiFlex Device to the spinous process;&#xD;
&#xD;
         13. The estimated distance between the LimiFlex Device strap attachment points (midpoint&#xD;
             of the cranial edge of the cranial spinous process and the midpoint of the caudal edge&#xD;
             of the caudal spinous process) is &lt;30mm on pre-operative lateral standing radiographs&#xD;
             at the segment to be instrumented;&#xD;
&#xD;
         14. Degenerative lumbar scoliosis with a Cobb angle &gt;10° at the affected motion segment;&#xD;
&#xD;
         15. Symptomatic lumbar stenosis that is not amenable to a direct decompression&#xD;
&#xD;
         16. Anklyosed motion segment at the target operative level&#xD;
&#xD;
         17. Severe osteoporosis, defined as history of fragility fracture and DXA T-score &lt;-2.5 or&#xD;
             QCT T-score &lt; -2.5. History of a fragility fracture requires that a DXA scan or QCT&#xD;
             scan is completed;&#xD;
&#xD;
         18. Planned hip or knee replacement surgery;&#xD;
&#xD;
         19. Documented allergy to titanium or polyethylene;&#xD;
&#xD;
         20. Active local or systemic infection;&#xD;
&#xD;
         21. Receiving immunosuppressive or long-term steroid therapy;&#xD;
&#xD;
         22. Known history of bone metabolic disorder, including Paget's disease,&#xD;
             hyperparathyroidism, renal osteodystrophy, and osteomalacia;&#xD;
&#xD;
         23. Disease or condition that would preclude accurate clinical evaluation of the safety&#xD;
             and effectiveness of the study treatment or any significant medical conditions which&#xD;
             would place the patient at excessive risk for surgery, such as:&#xD;
&#xD;
               1. severe rheumatoid arthritis or other severe autoimmune disease&#xD;
&#xD;
               2. active hepatitis (viral or serum) or HIV positive&#xD;
&#xD;
               3. unstable cardiac disease&#xD;
&#xD;
               4. uncontrolled diabetes&#xD;
&#xD;
               5. renal failure&#xD;
&#xD;
               6. severe muscular, neural or vascular diseases that endanger the spinal column&#xD;
&#xD;
               7. cauda equina syndrome&#xD;
&#xD;
               8. severe neurologic disorders including paralysis&#xD;
&#xD;
         24. Morbid obesity defined as BMI &gt;40;&#xD;
&#xD;
         25. History of malignancy within the last five years;&#xD;
&#xD;
         26. Women who are pregnant or are interested in becoming pregnant within the study period;&#xD;
&#xD;
         27. Currently seeking or receiving worker's compensation for back pain or spinal&#xD;
             condition;&#xD;
&#xD;
         28. Currently involved in spinal litigation that potentially is associated with secondary&#xD;
             financial gain;&#xD;
&#xD;
         29. Current involvement in a study of another investigational product for similar purpose;&#xD;
&#xD;
         30. Demonstrates three or more Waddell's Signs of Inorganic Behavior;&#xD;
&#xD;
         31. Active treatment of a major psychiatric condition, such as major depression, anxiety&#xD;
             disorder, bipolar disorder, schizophrenia, personality disorder, that could prevent&#xD;
             accurate completion of self reporting assessment scales;&#xD;
&#xD;
         32. Current history (within 12 months) of substance abuse, including alcohol abuse; or&#xD;
&#xD;
         33. A prisoner.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>25 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Rick Sasso, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Indiana Spine Group</affiliation>
  </overall_official>
  <overall_official>
    <last_name>William C Welch, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Pennsylvania Hospital Neurosurgery</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Sonoran Spine Research and Education Foundation</name>
      <address>
        <city>Tempe</city>
        <state>Arizona</state>
        <zip>85281</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kaiser Permanente Division of Research</name>
      <address>
        <city>Oakland</city>
        <state>California</state>
        <zip>94611</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Stanford University Medical Center</name>
      <address>
        <city>Redwood City</city>
        <state>California</state>
        <zip>94063</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>UC Davis Spine Center</name>
      <address>
        <city>Sacramento</city>
        <state>California</state>
        <zip>95816</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kaiser Permanente Roseville Clinical Trials Program</name>
      <address>
        <city>Sacramento</city>
        <state>California</state>
        <zip>95825</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>UCSF Dept of Orthopaedic Surgery</name>
      <address>
        <city>San Francisco</city>
        <state>California</state>
        <zip>94143</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Spine Institute, Center for Spinal Restoration and Foundation for Spinal Restoration</name>
      <address>
        <city>Santa Monica</city>
        <state>California</state>
        <zip>90403</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Boulder Neurological &amp; Spine Associates</name>
      <address>
        <city>Boulder</city>
        <state>Colorado</state>
        <zip>80303</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Miami, Dept of Neurological Surgery</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33136</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>BioSpine</name>
      <address>
        <city>Tampa</city>
        <state>Florida</state>
        <zip>33607</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Emory University</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30329</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Rush University</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60612</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Indiana Spine Group</name>
      <address>
        <city>Carmel</city>
        <state>Indiana</state>
        <zip>46032</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Norton Leatherman Spine Center</name>
      <address>
        <city>Louisville</city>
        <state>Kentucky</state>
        <zip>40202</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Beth Israel Deaconess Medical Center</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02215</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Massachusetts, Dept of Orthopedics and Physical Rehabilitation</name>
      <address>
        <city>Worcester</city>
        <state>Massachusetts</state>
        <zip>01605</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Beaumont Hospital</name>
      <address>
        <city>Royal Oak</city>
        <state>Michigan</state>
        <zip>48073</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Michigan Head and Spine Institute</name>
      <address>
        <city>Royal Oak</city>
        <state>Michigan</state>
        <zip>48073</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Washington University School of Medicine</name>
      <address>
        <city>Saint Louis</city>
        <state>Missouri</state>
        <zip>63110</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>UHS Neurosurgery (Binghamton)</name>
      <address>
        <city>Binghamton</city>
        <state>New York</state>
        <zip>13760</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital for Special Surgery</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10021</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>SUNY Upstate Medical University</name>
      <address>
        <city>Syracuse</city>
        <state>New York</state>
        <zip>13210</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Ohio State University</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43210</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Pennsylvania Hospital</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19106</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Texas Back Institue, Clincal Research, LLC-Plano</name>
      <address>
        <city>Plano</city>
        <state>Texas</state>
        <zip>75093</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Virginia Orthopaedic Surgery</name>
      <address>
        <city>Charlottesville</city>
        <state>Virginia</state>
        <zip>22908</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Swedish Medical Center</name>
      <address>
        <city>Seattle</city>
        <state>Washington</state>
        <zip>98122</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>December 2020</verification_date>
  <study_first_submitted>March 31, 2017</study_first_submitted>
  <study_first_submitted_qc>April 11, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">April 14, 2017</study_first_posted>
  <last_update_submitted>December 16, 2020</last_update_submitted>
  <last_update_submitted_qc>December 16, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">December 19, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Spinal Stenosis</mesh_term>
    <mesh_term>Spondylolisthesis</mesh_term>
    <mesh_term>Constriction, Pathologic</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

